MIR3690

Across TCGA pan-cancer cohorts, MIR3690 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR3690 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher MIR3690 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MIR3690 expression acts as an unfavorable survival marker, although some lineages such as CESC and PAAD show a favorable association.

CESC, LIHC, and UVM are the cancer types where MIR3690 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	II,III,IV	1.000	0.470	.007	48	view →
LIHC	OS	Tertile	II,III,IV	0.501	0.732	.011	42	view →
UVM	OS	Tertile	All	0.248	0.769	.007	36	view →
THCA	OS	Tertile	IV	0.770	0.972	<.001	36	view →
BRCA	OS	Tertile	III,IV	0.801	0.918	.014	33	view →
LGG	OS	Tertile	All	0.311	0.508	.003	25	view →
CHOL	OS	Tertile	All	0.089	0.673	.018	18	view →
THYM	DFS	Tertile	All	0.757	0.949	.020	12	view →
PRAD	OS	Tertile	All	0.972	0.996	.004	12	view →
PAAD	OS	Tertile	II,III,IV	0.532	0.332	.041	10	view →
ESCA	OS	Tertile	II,III,IV	0.464	1.000	.023	9	view →
SKCM	DFS	Tertile	IV	0.134	0.589	.031	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR3690–CESC (OS)

Open the CESC breakdown →